Your browser doesn't support javascript.
loading
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.
Reck, Folkert; Alm, Richard A; Brassil, Patrick; Newman, Joseph V; Ciaccio, Paul; McNulty, John; Barthlow, Herbert; Goteti, Kosalaram; Breen, John; Comita-Prevoir, Janelle; Cronin, Mark; Ehmann, David E; Geng, Bolin; Godfrey, Andrew Aydon; Fisher, Stewart L.
Affiliation
  • Reck F; Infection Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States. folkert.reck@novartis.com
J Med Chem ; 55(15): 6916-33, 2012 Aug 09.
Article in En | MEDLINE | ID: mdl-22779424

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Quinolones / Dioxanes / Topoisomerase II Inhibitors / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2012 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Quinolones / Dioxanes / Topoisomerase II Inhibitors / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2012 Type: Article Affiliation country: United States